Expression of tenascin in human cervical cancer - Association of tenascin expression with clinicopathological parameters

Gynecologic Oncology

Volumn 73, Issue 3, 1999, Pages 415-421

  Pilch, H ^a   Schaffer U ^a   Schlenger, K ^a   Lautz, A ^a   Tanner, B ^a   Hockel M ^b   Knapstein, P G ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Human cervical cancer; Immunohistochemistry; Tenascin

Indexed keywords

MONOCLONAL ANTIBODY; TENASCIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY; SURVIVAL TIME; TUMOR GROWTH; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0344689832     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5405     Document Type: Article

References (32)

1. Speiser P, Wanner C, Tempfer C, Mittelböck M, Hanzal E, Bancer D, Gitsch G, Reitaller A, Kainz C. CD44 is an independent prognostic factor in early-stage cervical cancer. Int J Cancer. 74:1997;185-188.
2. Falk S, Falk C, Stutte H J. Local immunoreactions in CIN and cervical carcinoma - a histological and immunohistological study. Geburts u Frauenheilk. 51:1991;39-44.
3. Aufderheide E, Chiquet-Ehrismann R, Ekblom P. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchym. J Cell Biol. 105:1987;599-608.
4. Christensen L, Nielsen M, Anderson J, Clemmensen I. Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma. Cancer Res. 48:1988;6227-6233.
5. Fujita S, Suzuki H, Kinoshita M, Hirohashi S. Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin β1 subunit antibody. Jpn J Cancer Res. 83:1984;219-229.
6. Mackie E J, Chiquet-Ehrismann R, Pearson C A, Inaguma Y, Taya K, Kawarada Y, Sakatura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA. 84:1987;4621-4625.
7. Chiquet-Ehrismann R, Mackie E J, Pearson C A, Sakatura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 47:1986;131-139.
8. Chiquet-Ehrismann R, Matsuoka Y, Hofer U, Spring J, Bernasconi C, Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul. 2:1991;927-938.
9. Erikson H P, Bourdon M A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumours. Annu Rev Cell Biol. 5:1989;71-92.
10. Chiquet M, Fambrough D M. Chick myotendinous antigen. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 98:1984;1926-1936.
11. Mackie E J, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 107:1988;2757-2769.
12. Inaguma Y, Kusakabe M, Mackie E J, Pearson C A, Chiquet-Ehrismann, Sakatura T. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol. 128:1988;245-255.
13. Lee S K, Park S C, Chi J G, Sakamato F, Shresta P, Mori M. Expression of tenascin in hamster buccal pouch mucosa during experimental carcinogenesis. Oral Oncol Eur J Cancer. 31B:1995;188-192.
14. Pearson C A, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-β EMBO J. 7:1988;2977-2981.
15. Jones F S, Burgoon M P, Hoffmann S, Crossin K L, Cunnigham B A, Edelmann G M. A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci USA. 85:1988;2186-2190.
16. Scully. International Histological Classification of Tumours. 1994.
17. Hermanek P, Sobin L H. TNM Classification of Malignant Tumours. 1997;Springer and International Union Against Cancer, New York.
18. Remmele W, Stegner H E. Rezeptorbestimmung in Mammakarzinomgewebe. Dt Ärztebl Ausgabe A. 48:1986;3359.
19. Ikeda Y, Mori M, Kajiyama K, Haraguchi Y, Sasaki O, Sugimachi K. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes. Br J Cancer. 72:1995;189-192.
20. Soini Y, Paako P, Nuorva K, Kamel D, Linnala A, Virtanen I, Lehto V P. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol. 100:1993;145-150.
21. Sakai T, Kawakatsu H, Hirota N, Yokoyama T, Sakakura T, Saito M. Specific expression of tenascin in human colonic neoplasms. Br J Cancer. 67:1993;1059-1064.
22. Natali P G, Nicotra M R, Bigotti A, Botti C, Castellani P, Risso A M, Zardi L. Expression and production of tenascin in benign and malignant lesions of melanocyte lineage. Int J Cancer. 46:1990;586-590.
23. Moch H, Torhorst J, Dürmüller U, Feichter G E, Sauter G, Gudat F. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Path Res Pract. 189:1993;510-514.
24. Chiquet-Ehrismann, R, Kalla, P, Pearson, C, A, Participation of tenascin and transforming growth factor beta in reciprocal epithelial-mesenchymal interactions of MCF cells and fibroblasts, Cancer Res, 49: 4322, - 4325.
25. Howeedy A A, Virtanen I, Laitinen L, Gould N S, Koukoulis G K, Gould V E. Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast. Lab Invest. 63:1990;798-806.
26. Koukoulis G K, Gould V E, Bhattacharyya A, Gould I P, Howeedy A A, Virtanen I. Tenascin in normal, reactive, hyperplastic and neoplastic tissues: biologic and pathologic implications. Human Pathol. 22:1991;636-643.
27. Ekblom P, Aufderheide E. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol. 33:1989;71-79.
28. Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation. FEBS Lett. 251:1989;1-7.
29. Probsmeier R, Martini R, Schachter M. Expression of J1/tenascin in the crypt villus unit of adult mouse small intestine: implications for ist role in epithelial cells shedding. Development. 109:1990;313-321.
30. Chiquet-Ehrismann R, Kalla P, Pearson C A, Beck K, Chiquet M. Tenascin interferes with fibronection action. Cell. 53:1988;383-390.
31. Tetsuji S, Tomoo K, Airo T, Yoshinori H, Takehiko H, Koshiro H, Sokokichi M. Tenascin positivity and the survival of patients with invasive breast carcinoma. J Surg Res. 55:1993;295-297.
32. Sugawara I. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis. Invas Metast. 11:1991;325-331.